| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Tranche C Warrants (right to buy) | 18.6M | $0.74 | $13.8M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Tranche B Warrants (right to buy) | 11.6M | $0.59 | $6.9M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Tranche A Warrants (right to buy) | 12.8M | $0.54 | $6.9M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Series A-2 Preferred Stock | 13.4M | $0.00 | $0 | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Series A-1 Preferred Stock | 8.1k | $1,000.00 | $8.1M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Unicycive Therapeutics, Inc. | UNCY | Conversion | Common Stock | 3.5M | $0.00 | $0 | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 03/08/2023 | Unicycive Therapeutics, Inc. | UNCY | Grant | Series A-1 Convertible Preferred Stock | 8.1k | $1,000.00 | $8.1M | By Vivo Opportunity Fund Holdings, L.P. | 03/08/2023 |
| 07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Common Stock | 2.7M | $55.00 | $150.5M | By: Vivo Opportunity Fund Holdings, L.P. | 07/01/2022 |
| 07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 1.5k | $13.87 | $20.8k | | 07/01/2022 |
| 07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 6.9k | $13.98 | $96.1k | | 07/01/2022 |
| 07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 6k | $18.11 | $108.7k | | 07/01/2022 |
| 07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Series A Warrant | 1.5M | $13.20 | $19.2M | By: Vivo Opportunity Fund Holdings, L.P. | 07/01/2022 |
| 01/31/2022 | Sierra Oncology, Inc. | SRRA | Purchase | Common Stock | 800k | $27.00 | $21.6M | By Vivo Opportunity Fund, L.P. | 01/31/2022 |
| 01/26/2022 | Sierra Oncology, Inc. | SRRA | Exercise (in-the-money or at-the-money) | Series B Warrant (Right to Purchase) | 1.5M | $13.20 | $19.2M | By Vivo Opportunity Fund, L.P. | 01/26/2022 |
| 06/08/2021 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (Right To Buy) | 6k | $18.11 | $108.7k | | 06/08/2021 |
| 06/09/2020 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (right to buy) | 6.9k | $13.98 | $96.1k | | 06/09/2020 |
| 01/29/2020 | Sierra Oncology, Inc. | SRRA | Conversion | Common Stock | 1.5M | $0.00 | $0 | By Vivo Opportunity Fund, LP | 01/29/2020 |
| 01/29/2020 | Sierra Oncology, Inc. | SRRA | Conversion | Series A Convertible Voting Preferred Stock | 19.2k | $0.00 | $0 | By Vivo Opportunity Fund, LP | 01/29/2020 |
| 11/29/2019 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (Right to Buy) | 60k | $0.35 | $20.8k | | 11/29/2019 |
| 04/30/2014 | Ocera Therapeutics, Inc. | OCRX | Grant | | 175k | $8.26 | $1.4M | | 04/30/2014 |